Mrv0541 02231218122D 14 15 0 0 1 0 999 V2000 3.6703 -0.2897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.2021 0.6122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.0993 -1.9398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.9558 0.9478 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.8695 1.7683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0625 1.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 1.2253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6703 0.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3847 -0.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3847 -1.5273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0993 -0.2897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6703 -1.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8137 -0.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8137 -1.5273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 8 1 0 0 0 0 1 9 1 0 0 0 0 2 4 1 0 0 0 0 2 7 1 0 0 0 0 3 10 1 0 0 0 0 3 14 2 0 0 0 0 4 5 1 0 0 0 0 4 8 1 1 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 9 10 2 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 11 13 2 0 0 0 0 13 14 1 0 0 0 0 M END > DB05458 > drugbank > CC1=C(OC[C@@H]2CCCN2)C=CC=N1 > InChI=1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1 > YRVIKLBSVVNSHF-JTQLQIEISA-N > C11H16N2O > 192.2575 > 192.126263144 > 3 > 30 > 1.042490740599029 > 21.744879778595724 > 1 > 1 > 0 > 1 > 2-methyl-3-{[(2S)-pyrrolidin-2-yl]methoxy}pyridine > 1.16 > 0.8304334140000005 > -1.17 > 0 > 1 > 2 > 1 > 10.474604783454586 > 34.15 > 54.8914 > 3 > 1 > 1.31e+01 g/l > tetrahydrofolic acid > 1 > DB05458 > investigational > Pozanicline > Pozanicline $$$$